Oxytocin (Uterotonic)
High-yield Verified · Oct 2026Most hormones switch themselves off; oxytocin switches itself on. Each contraction it causes releases more oxytocin — and the same drug that finishes labor can, in excess, starve the fetus of oxygen or flood the mother with water.
Nursing view → administration, monitoring and patient teaching
Compare: Labor drugs compared — uterotonics, tocolytics and magnesium sulfate →
Drugs
Mechanism
Binds uterine oxytocin receptors, increasing intracellular calcium and the frequency and force of myometrial contractions. Also promotes milk let-down. Its ADH-like activity can cause water retention at high, prolonged doses.
A posterior-pituitary hormone with positive feedback
Oxytocin is a nonapeptide made in the paraventricular nucleus of the hypothalamus and stored in and released from the posterior pituitary (pars nervosa). Unlike most hormones — including ADH (vasopressin), the other posterior-pituitary hormone, which shows negative feedback — oxytocin shows positive feedback: its release leads to actions that release even more.
In labor, the fetal head pushes against the cervix, nerve impulses travel to the mother’s brain, and the posterior pituitary secretes oxytocin, which travels in the blood to the uterus and strengthens contractions; the cycle continues until delivery. In the breast, oxytocin contracts the myoepithelial cells of the alveolar ducts and forces milk out. A baby latching on triggers oxytocin release in the same way, so the milk-ejection reflex is also positive feedback. An intranasal form was once used in the United States to encourage milk ejection after delivery.
Receptor → calcium → contraction, and why term matters
Oxytocin binds G protein–coupled receptors on the myometrium that raise inositol triphosphate and intracellular calcium. Uterine motility depends on actomyosin formed under the calcium-dependent myosin light-chain kinase, so more calcium means stronger, more frequent contractions.
The myometrial receptor concentration rises greatly during pregnancy, peaking in early labor at term. The response to a given dose is therefore very individual and depends on the uterus’s sensitivity, which the receptor concentration sets; before term, sensitivity is lower and higher infusion rates may be needed. Because the dose response is not predictable, the drug is judged by the intensity and frequency of contractions.
Labor, the box, and the third stage
The label indicates oxytocin to start or improve contractions for a medical reason: induction (for example Rh problems, maternal diabetes, preeclampsia at or near term, or ruptured membranes when delivery is indicated), stimulation of labor in uterine inertia, and adjunctive treatment of incomplete or inevitable abortion. For induction or augmentation it is given only by IV infusion, on a pump, in hospital, starting very low and adjusted to the uterine response. Its boxed Important Notice: because the data cannot weigh benefit against risk, Pitocin is not indicated for elective induction — labor started without a medical indication.
After delivery, it produces contractions in the third stage and controls postpartum bleeding. Uterine atony — a soft, boggy uterus that has not contracted after delivery — is the most common cause of postpartum hemorrhage, and initial medical management uses drugs that improve uterine tone and induce contractions. WHO recommends a uterotonic at every birth to prevent hemorrhage (oxytocin is one of the options) and recommends IV oxytocin as the first-line uterotonic for treating it, even when it was already given for prevention. Other uterotonics include methylergonovine, carboprost and misoprostol, which a later page covers. Prolonged oxytocin use and magnesium sulfate infusions are themselves risk factors for atony.
Too much: hyperstimulation, and the vasopressin likeness
Overstimulation — strong (hypertonic) or prolonged (tetanic) contractions, or a high resting tone between them — can cause tumultuous labor, uterine rupture, lacerations, postpartum hemorrhage and uteroplacental hypoperfusion with variable decelerations, fetal hypoxia and death. Hypertonic contractions can occur even with proper use in a hypersensitive uterus. The response is to stop the infusion at once and give the mother oxygen, preferably lying on her side; its plasma half-life is only minutes, and the IV uterine response subsides within an hour.
Oxytocin and vasopressin differ in only two amino acids, so oxytocin has inherent pressor and antidiuretic properties at large doses. Its antidiuretic effect increases water reabsorption from the glomerular filtrate, and large doses infused for long periods — especially while the patient drinks — can cause water intoxication with convulsions, coma and maternal death. Treatment is to stop the oxytocin and any free water, replacing electrolyte-free water with isotonic saline. (ADH physiology and hyponatremia are on the Pituitary / ADH Agents page.) A rapid undiluted infusion can cause hypotension.
Pharmacokinetics
- Onset and duration
- IV: uterine response almost immediately, subsiding within 1 hour. IM: response within 3–5 minutes, lasting 2–3 hours.
- Half-life
- Plasma half-life about 1–6 minutes, shorter in late pregnancy and during lactation.
- Distribution
- Extracellular fluid; small amounts probably reach the fetal circulation.
- Metabolism and elimination
- Cleared rapidly, mainly by the kidney and liver, with little excreted unchanged in urine. Oxytocinase, for which the placenta is a key site of synthesis, breaks it down; its activity rises through gestation and peaks near term.
Uses & drug choice
- Induction and augmentation of labor (with a medical indication)
- Prevention and treatment of postpartum hemorrhage (uterine atony)
- Adjunctive therapy in incomplete or inevitable abortion
Adverse effects
- Tachysystole and fetal compromise
- Excess receptor stimulation gives hypertonic or tetanic contractions → uteroplacental hypoperfusion, variable decelerations, fetal hypoxia; in the newborn, bradycardia, arrhythmias, low Apgar scores, seizures and brain damage are reported.
- Uterine rupture
- Forceful contractions against a uterus predisposed to rupture — hence the warning against oxytocin after major uterine or cervical surgery, including cesarean section, except in unusual circumstances.
- Water intoxication
- Intrinsic antidiuretic effect (vasopressin-like structure) at large doses over long periods, worse with oral fluids.
- Hypotension
- Rapid undiluted infusion (WHO advises avoiding rapid IV injection to reduce the risk of hypotension); cyclopropane anesthesia can also change oxytocin’s cardiovascular effects, producing hypotension and maternal bradycardia.
- Severe hypertension
- Oxytocin given hours after a prophylactic vasoconstrictor with caudal block anesthesia.
- Excessive contractions with other uterotonics
- Carboprost or misoprostol add to oxytocin’s effect, so combining oxytocic drugs is avoided where possible.
Contraindications
- Significant cephalopelvic disproportion — The fetus cannot safely descend; forcing contractions risks obstructed labor and uterine rupture.
- Fetal distress where delivery is not imminent — Adding contractions further reduces placental perfusion to an already-compromised fetus.
- Uterus already hyperactive or hypertonic — More stimulation risks hyperstimulation — tetanic contractions, uterine rupture, and fetal hypoxia.
- Unfavorable fetal positions or presentations undeliverable without conversion (e.g., transverse lie) — Forcing contractions against a presentation that cannot deliver vaginally risks obstructed labor and uterine rupture.
- Previous major surgery on the uterus or cervix, including cesarean section (e.g., classical incision) use caution — A scarred uterus is predisposed to rupture — the label says not to give oxytocin here except in unusual circumstances.
- Elective induction without a medical indication — Boxed notice: the data are inadequate to weigh benefits against risks, so oxytocin is not indicated for elective induction.
- Vaginal delivery contraindicated — e.g., invasive cervical cancer, active genital herpes, total placenta previa, vasa previa, cord presentation or prolapse — Oxytocin is given to bring about vaginal birth; the label contraindicates it whenever vaginal delivery itself is contraindicated.
- Obstetric emergencies where the benefit-to-risk balance for mother or fetus favors surgical delivery — The label contraindicates stimulating labor when surgical intervention is the better option for the mother or the fetus.
- Adequate uterine activity that is failing to achieve satisfactory progress — The label contraindicates further stimulation when contractions are already adequate but labor is not progressing; added stimulation risks hyperstimulation.
- Hypersensitivity to oxytocin — Anaphylactic reactions have been reported in mothers given oxytocin.
High-yield
Practice questions
Q1A 31-year-old woman at 41 weeks and another at 34 weeks both receive oxytocin for medically indicated induction. The woman at term contracts strongly at a low infusion rate, while the woman at 34 weeks needs a higher rate.
What best explains the difference?
- A.Oxytocin’s half-life is longer late in pregnancy
- B.At term, oxytocin acts through Gs-coupled receptors that raise cAMP
- C.Placental oxytocinase activity falls toward term
- D.Myometrial oxytocin receptor concentration rises through pregnancy and peaks at term
Show answer
D. Myometrial oxytocin receptor concentration rises through pregnancy and peaks at term — Oxytocin receptors in the myometrium increase greatly during pregnancy and peak in early labor at term; the uterus’s sensitivity, set by the receptor concentration, determines the response, so before term a higher rate may be needed. The half-life is shorter, not longer, in late pregnancy; oxytocin raises inositol triphosphate and intracellular calcium; and oxytocinase activity rises, peaking near term.
Q2A 26-year-old woman has received an oxytocin infusion for most of a day during a long induction and has been drinking water freely. She develops headache, confusion and then a seizure; her serum sodium is 118 mEq/L.
Which step addresses the cause?
- A.Increase the oxytocin rate to complete the delivery quickly
- B.Change the oxytocin diluent to 5% dextrose in water
- C.Stop the oxytocin and free water and replace them with isotonic saline
- D.Continue oxytocin and restrict only oral fluids
Show answer
C. Stop the oxytocin and free water and replace them with isotonic saline — Oxytocin and vasopressin differ in only two amino acids, and oxytocin’s intrinsic antidiuretic effect increases water reabsorption; large doses over long periods, especially with oral fluids, cause water intoxication with convulsions. Treatment is to stop the oxytocin infusion and any free water and replace electrolyte-free water with isotonic saline. Continuing or increasing oxytocin keeps the antidiuretic effect going, and the label’s infusion is made in 0.9% sodium chloride or Ringer’s lactate.
Q3A 29-year-old woman is being induced with oxytocin. Her contractions now come every minute with almost no rest between them, and the fetal heart rate shows repeated decelerations.
What should be done first?
- A.Stop the oxytocin infusion and give the mother oxygen in a lateral position
- B.Increase the oxytocin rate to shorten labor
- C.Switch the oxytocin to an intramuscular injection
- D.Continue the infusion and recheck in an hour
Show answer
A. Stop the oxytocin infusion and give the mother oxygen in a lateral position — Hyperstimulation causes uteroplacental hypoperfusion, variable decelerations and fetal hypoxia, and can rupture the uterus. The label says to stop the infusion immediately in uterine hyperactivity or fetal distress and to give the mother oxygen, preferably in a lateral position; with a plasma half-life of about 1–6 minutes, the effect fades quickly. More oxytocin or waiting prolongs the overstimulation, and an intramuscular dose acts for 2–3 hours.
Q4A 33-year-old woman nursing her 5-day-old infant notices milk dripping from both breasts within a minute of the baby latching on.
Which mechanism explains the milk ejection?
- A.Oxytocin from the anterior pituitary acting on the uterus
- B.Negative feedback that lowers oxytocin release as suckling continues
- C.Oxytocin stimulating the breast to synthesize more milk
- D.Oxytocin released from the posterior pituitary contracting myoepithelial cells around the alveolar ducts
Show answer
D. Oxytocin released from the posterior pituitary contracting myoepithelial cells around the alveolar ducts — Suckling triggers oxytocin release from the posterior pituitary, and oxytocin contracts the myoepithelial cells of the alveolar ducts, forcing milk out; like labor, the milk-ejection reflex runs on positive feedback. Oxytocin is stored in the posterior, not anterior, pituitary, and it ejects milk already made by squeezing the ducts rather than by increasing synthesis.
Sources
- Oxytocin — uterine action, tachysystole, water intoxication, high-alert use — StatPearls (NCBI)
- PITOCIN (oxytocin) — contraindications, warnings (hyperstimulation, not for elective induction), adverse reactions, FDA label — FDA / DailyMed
- Hemodynamic effects of continuous vs bolus oxytocin in cesarean section (Korean J Anesthesiol 2011) — PMC (open access)
- Anesthesia for Labor, Delivery, and Cesarean Section in High-Risk Heart Disease — oxytocin and vascular resistance — StatPearls (NCBI)
- High-Risk Perinatal Client Care — oxytocin administration box (Nursing Health Promotion) — Open RN (NCBI Bookshelf)
- Drugs@FDA marketing status — Pitocin — U.S. FDA (openFDA)
- Uterine Atony — boggy uterus, third-stage management — StatPearls (NCBI)
- Fetal Heart Rate Tracing — fetal oxygenation during contractions — StatPearls (NCBI)
- Labor augmentation update — bolus IV fluids when tachysystole persists with non-reassuring FHR (Matern Fetal Med, CC BY-NC-ND) — Maternal-Fetal Medicine via PMC
- Intrauterine resuscitation — position change, stopping oxytocin, IV fluids, oxygen (PLoS ONE, CC BY) — PLoS ONE via PMC
- Fetal distress interventions — lateral tilt, IV fluids, oxygen (BMC, CC BY) — BMC via PMC
- Postpartum Hemorrhage — uterine atony as the most common cause — StatPearls (NCBI)
- Tocolysis — oxytocin receptor signaling (inositol triphosphate) — StatPearls (NCBI)
- WHO consolidated guidelines on postpartum haemorrhage (2025) — uterotonics for prevention and treatment, avoiding rapid IV injection — World Health Organization
By LearnDrugs
Educational summary for medical students. Always verify against current prescribing information and guidelines. Not medical advice.